| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BENCHMARK HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 16.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.01.2026 | 705 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 16.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.01.2026ISIN NameCA91831M1059 VR... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 56,52 | -0,07 % | Deutsche Telekom-Aktie und Bayer-Aktie: Was steckt noch drin? | Die deutschen Börsen bleiben von unterschiedlichen Erwartungen an die großen DAX-Konzerne geprägt. Besonders die Aktien der Deutschen Telekom und von Bayer stehen im Fokus: Während der Telekom stabile... ► Artikel lesen | |
| NOVO NORDISK | 37,740 | -0,07 % | DEUTSCHE BANK RESEARCH stuft NOVO NORDISK auf 'Sell' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Novo Nordisk nach einem genaueren Blick auf die Resultate des dritten Quartals mit einem Kursziel von 240 dänischen Kronen... ► Artikel lesen | |
| GSK | 22,910 | +0,70 % | Dividendenbekanntmachungen (12.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEBI SCHMIDT HOLDING AG CH0027352993 0,025 USD 0,0225 EUR AIRTEL AFRICA PLC GB00BKDRYJ47 0,031 USD 0,0279 EUR ALLWYN AG GRS419003009 - ... ► Artikel lesen | |
| INNOCAN PHARMA | 1,005 | +5,79 % | InnoCan Pharma: Neue Finanzierung und frische Vertriebs-News - wie weit trägt das? | ||
| EYEPOINT | 0,284 | +0,71 % | Stifel cuts EyePoint stock price target on trial setbacks | ||
| EDWARDS LIFESCIENCES | 97,16 | -0,08 % | Edwards Lifesciences stock rating maintained at Buy by TD Cowen | ||
| NOVERIS HEALTH SCIENCES | 0,025 | 0,00 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Commencement of Strategic Review Process | Vancouver, British Columbia--(Newsfile Corp. - November 13, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces that its board of directors... ► Artikel lesen | |
| HAPPY BELLY FOOD GROUP | 0,895 | -0,56 % | Happy Belly Food Group Inc.: Happy Belly Food Group's Heal Wellness QSR Announces the Grand Opening of Its 56th Location in Collingwood, Ontario | Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,011 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake appoints Dehaan as CEO | ||
| JAZZ PHARMACEUTICALS | 219,60 | +0,27 % | Piper Sandler raises Jazz Pharmaceuticals price target on Ziihera outlook | ||
| DAIICHI SANKYO | 16,246 | -0,85 % | Daiichi Life Group, Inc. Profit Advances In H1 | TOKYO (dpa-AFX) - Daiichi Life Group, Inc. (DLICY) announced earnings for its first half that Increased, from the same period last yearThe company's earnings totaled JPY283.815 billion, or JPY78.78... ► Artikel lesen | |
| PSYCHED WELLNESS | 0,002 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Announces Secured Term Loan | Toronto, Ontario--(Newsfile Corp. - November 6, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production... ► Artikel lesen | |
| SWEET EARTH | 0,324 | 0,00 % | Vesalius Longevity Labs Inc.: Vesalius Longevity Labs Appoints Harvey Spevak as Chairman to Accelerate Global Growth and Brand Development | Appointment Follows US$6.5 Million Strategic Financing and Strengthens Board Leadership Alongside David Adelman, Kevin Mayer, Lee Applbaum and James McRobertsVancouver, British Columbia and Scottsdale... ► Artikel lesen | |
| H LUNDBECK | 7,930 | -0,50 % | H. Lundbeck A/S: Lundbeck raises full-year guidance as 9M revenue grows +13% CER (+11% CER underlying) and adjusted EBITDA +19% CER, led by Vyepti | Lundbeck raises full-year guidance as 9M revenue grows +13% CER (+11% CER underlying) and adjusted EBITDA +19% CER, led by Vyepti
VALBY, Denmark, Nov. 10, 2026 /PRNewswire/ --
Key highlightsLundbeck's... ► Artikel lesen | |
| AYTU BIOPHARMA | 1,900 | -100,00 % | Aytu BioPharma, Inc.: Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026 | DENVER, CO / ACCESS Newswire / November 10, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central... ► Artikel lesen |